Back
Innate Pharma SA Vs. Arcellx Industry Stock Comparison
Sell
40
IPHA
Innate Pharma SA
Last Price:
$2.11
Seasonality Move:
-9.96%
Sell
47
ACLX
Arcellx
Last Price:
$58.39
Seasonality Move:
35.84%
Sell
40
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.08. The Score for IPHA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
IPHA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Arcellx (ACLX)
is a Sell
Is Arcellx a Buy, Sell or Hold?
-
ACLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.08The current trend is moderately bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.
ACLX Stock Price Chart
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 47.62 | Sell |
Chaikin Money Flow: | -16852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.91 - 2.27) | Sell |
Bollinger Bands (100): | (1.81 - 2.17) | Buy |
ACLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.57 | Sell |
Relative Strength Index (14 RSI): | 45.73 | Sell |
Chaikin Money Flow: | -139326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.2 - 64.48) | Sell |
Bollinger Bands (100): | (60.36 - 72.42) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.27 | Sell |
20-day SMA: | 2.15 | Sell |
50-day SMA: | 2.02 | Buy |
200-day SMA: | 2 | Buy |
8-day EMA: | 2.21 | Sell |
20-day EMA: | 2.16 | Sell |
50-day EMA: | 2.06 | Buy |
200-day EMA: | 2.07 | Buy |
ACLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.62 | Buy |
20-day SMA: | 61.22 | Sell |
50-day SMA: | 64.33 | Sell |
200-day SMA: | 72.97 | Sell |
8-day EMA: | 58.83 | Buy |
20-day EMA: | 60.38 | Sell |
50-day EMA: | 63.1 | Sell |
200-day EMA: | 67.64 | Sell |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arcellx Earnings Growth & ACLX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.81 per share, an increase next quarter of $0.10 per share, a decrease this year of $2.58 per share, and an increase next year of $0.45 per share.
Innate Pharma SA Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arcellx Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |